Literature DB >> 4128766

Letter: Autosomal assignment of the gene for the form of adenosine deaminase which is deficient in patients with combined immunodeficiency syndrome.

R P Creagan, J A Tischfield, E A Nichols, F H Ruddle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4128766     DOI： 10.1016/s0140-6736(73)92850-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Evaluation of adenosine deaminase and other purine salvage pathway enzymes in horses with combined immunodeficiency.

Authors:  T C McGuire; B Pollara; J J Moore; M J Poppie
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

Review 2.  The biochemical basis of immunodeficiency disease.

Authors:  K O Raivio
Journal:  Eur J Pediatr       Date:  1980-10       Impact factor: 3.183

3.  Argininosuccinic aciduria: assignment of the argininosuccinate lyase gene to the pter to q22 region of human chromosome 7 by bioautography.

Authors:  S L Naylor; R J Klebe; T B Shows
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

4.  Heterogeneity for adenosine deaminase deficiency: Expression of the enzyme in cultured skin fibroblasts and amniotic fluid cells.

Authors:  S H Chen; C R Scott; D R Swedberg
Journal:  Am J Hum Genet       Date:  1975-01       Impact factor: 11.025

5.  Animal model for immune dysfunction associated with adenosine deaminase deficiency.

Authors:  A Tedde; M E Balis; S Ikehara; R Pahwa; R A Good; P P Trotta
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

6.  Chromosome assignments of genes in man using mouse-human somatic cell hybrids: Cytoplasmic isocitrate dehydrogenase (IDH 1) and malate dehydrogenase (MDH 1) to chromosomes 2.

Authors:  R P Creagan; B Carritt; S Chen; R Kucherlapati; F A McMorris; F Ricciuti; Y H Tan; J A Tischfield; F H Ruddle
Journal:  Am J Hum Genet       Date:  1974-09       Impact factor: 11.025

7.  A normal level of adenosine deaminase activity in the red cell lysates of carriers and patients with severe combined immunodeficiency disease.

Authors:  P P Trotta; E M Smithwick; M E Balis
Journal:  Proc Natl Acad Sci U S A       Date:  1976-01       Impact factor: 11.205
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.